Abstract

There was no research activity on this project because the WHO-sponsored collaborative study on evaluation of MAPREC for type 1 and type 2 OPV is underway. The results will be discussed at the November 2002 meeting of the WHO to determine future direction of this project.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Center for Biologics Evaluation and Resarch - Viral Products (CBERVP)
Type
Intramural Research (Z01)
Project #
1Z01BK008001-13
Application #
6678981
Study Section
(LAMD)
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
2002
Total Cost
Indirect Cost